ECH1 and metabolic dysfunction-associated steatohepatitis: ECH1 also ameliorated hepatic steatosis and fibrosis, and liver damage in NASH model mice by repressing ferroptosis via the inhibition of the Erk pathway and the upregulation of GPX4 (112).